Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Cheng Su

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Scientific Reports|November 25, 2025
Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regressionChia-Mu Tu, Meng-Hsuan Lin, Chih-Peng Liu, et al.
Archives of Osteoporosis|March 6, 2025
Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trialsYing-Yu Wang, Yu-Cheng Su, Pei-Chun Lai, et al.
Inflammation and Regeneration|February 17, 2023
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritisFu-Yao Jiang, Yan-Zhu Zhang, Yuan-Hong Tai, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Scientific Reports|November 25, 2025
Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regressionChia-Mu Tu, Meng-Hsuan Lin, Chih-Peng Liu, et al.
Archives of Osteoporosis|March 6, 2025
Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trialsYing-Yu Wang, Yu-Cheng Su, Pei-Chun Lai, et al.
Inflammation and Regeneration|February 17, 2023
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritisFu-Yao Jiang, Yan-Zhu Zhang, Yuan-Hong Tai, et al.
Pageof 8